Fermentalg SA (EPA:ALGAE)

Market Cap	42.43M -13.8%
Revenue (ttm)	13.38M +16.4%
Net Income	-9.44M
EPS	-0.09
Shares Out	89.71M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	36,340
Open	0.4750
Previous Close	0.4720
Day's Range	0.4730 - 0.4795
52-Week Range	0.4000 - 0.6400
Beta	1.06
Analysts	Strong Buy
Price Target	0.68 (+43.76%)
Earnings Date	Jul 16, 2026

About Fermentalg

Fermentalg SA provides biosolutions based on aquatic micro-organisms in Europe, North America, Asia, and internationally. It offers DHA ORIGINS, a plant-based DHA oil; KALVEA PLUS, a nutritious algal protein concentrate dedicated to aquafeed applications; Everzure, an extract of natural acid stable blue color; BLUE ORIGINS AOX, an antioxidant and anti-inflammatory activities; and biobased raw materials for industry from their CO2 emissions. The company was incorporated in 2009 and is headquartered in Libourne, France.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2009
• Employees: 63
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALGAE

Financial Performance

In 2025, Fermentalg's revenue was 13.38 million, an increase of 16.41% compared to the previous year's 11.50 million. Losses were -9.44 million, -26.71% less than in 2024.

Analyst Summary

According to 2 analysts, the average rating for ALGAE stock is "Strong Buy." The 12-month stock price target is €0.68, which is an increase of 43.76% from the latest price.

Price Target

€0.68

(43.76% upside)

Analyst Consensus: Strong Buy